Skip to main content

Advertisement

SpringerLink
Log in

Bisphosphonates

  • Perspective
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 2002;23: 508–16.

    Article  PubMed  CAS  Google Scholar 

  2. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, et al. Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial. J Clin Endocrinol Metab 2000;85: 4118–24.

    Article  PubMed  CAS  Google Scholar 

  3. Bone HG, Hosking D, Devogelaer J, Tucci JR, Emkey RD, Tonino RP, et al. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004;350: 1189–99.

    Article  PubMed  CAS  Google Scholar 

  4. Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, et al. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocrine Rev 2002;23: 517–23.

    Article  CAS  Google Scholar 

  5. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344: 333–40.

    Article  PubMed  CAS  Google Scholar 

  6. Riis BJ, Ise J, Von Stein T, Bagger Y, Christiansen C. Ibandronate: A comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis. J Bone Mineral Res 2001;16: 1871–8.

    Article  CAS  Google Scholar 

  7. Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, et al. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget’s disease of bone. Bone 2004;35: 224–30.

    Article  PubMed  CAS  Google Scholar 

  8. Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget’s disease. N Engl J Med 2005;353: 898–908.

    Article  PubMed  CAS  Google Scholar 

  9. Selvaggi G, Scagliotti GV. Management of bone metastases in cancer: a review. Crit Rev Oncol/Hematol 2005;56: 365–78.

    Article  Google Scholar 

  10. Bilezikian JP. Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 2006;355: 2278–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand

    Ian R. Reid

Authors
  1. Ian R. Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian R. Reid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, I.R. Bisphosphonates. Skeletal Radiol 36, 711–714 (2007). https://doi.org/10.1007/s00256-006-0266-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-006-0266-2

Search

Navigation